Alveda Pharmaceutical

Alveda Pharmaceutical is a Canadian specialty pharmaceutical company that specializes in the development, licensing, and commercialization of injectable and specialty drug products. Headquartered in Toronto, Ontario, the company focuses on providing the Canadian healthcare system with essential generic medicines, particularly for hospital and clinical use. Its product portfolio includes a wide range of treatments in therapeutic areas such as anesthesia, pain management, and critical care. In 2015, Alveda was acquired by the U.S.-based specialty pharma company Teligent to serve as its Canadian platform. Following Teligent's financial restructuring in 2021, Alveda's portfolio and operations were subsequently integrated into other pharmaceutical entities, including SteriMax.